A new diagnostic strategy to improve the detection of pathogens in heart valves (HVs) from patients with infective endocarditis (IE) was evaluated.
Introduction
According to current guidelines, the diagnosis infective endocarditis (IE) is established if microbiological infection of the endocardium is demonstrated. The standard procedure includes clinical and echocardiographic findings plus identification of the causative pathogen. 1 In unclear cases, diagnosis may be based on Duke criteria. 2 Identification of the causative microorganism is crucial, not only for proper diagnosis, but also for appropriate antibiotic treatment and management decision, e.g. surgery during active IE. Blood cultures are accepted as the gold standard for pathogen identification and quantitative susceptibility testing. However, in up to 31% of suspected IE cases, 3, 4 blood cultures remain negative due to previous antibiotic treatment, 5 slow-growing, fastidious, or difficult-to-culture organisms, 6 or small amounts of microorganisms per volume. Patients with culture-negative endocarditis (CNE), often associated with more complicated courses, 7 may benefit from identification of pathogens by polymerase chain reaction (PCR) techniques. 1 As surgically removed infected heart valves (HVs) usually contain large numbers of pathogens, a PCR analysis is supposed to be much more effective. 8 -16 Cultures of surgically removed † T.V. and C.P. contributed equally to this study.
specimens often suffer the same limitations as blood cultures. Providing potential advantages, molecular genetic screening methods have been used in studies including small numbers of patients only and limited controls to confirm the validity of PCR results. The sensitivity of PCR diagnostics is influenced by falsenegative results due to amplification inhibitors in PCR assays, 17 contamination, 18 and owing to standardization of PCR. 19 Broadrange real-time PCR amplification has been established as standard in clinical laboratories because of enhanced assay sensitivity and a short diagnostic time delay. Real-time PCR allows for the calculation of the bacterial load by quantification of gene copies. However, real-time PCR has rarely been used for pathogen detection in HVs, due to environmental contamination of 16S rDNA real-time PCR assays. 19 Traditional inflammatory markers, such as white blood cell count (WBC) and C-reactive protein, as well as new parameters, e.g. lipopolysaccharide-binding protein 20 (LBP), are currently used to monitor the progression of infection 21 and the effect of antibiotic therapy. Although clearance of pathogens or pathogen DNA in HVs during effective antibiotic treatment is of prognostic importance, the concentration of the infective agent at the time of surgery is insufficiently examined. 11 In the present study, we analyse the sensitivity of the standard broad-range 16S rDNA PCR in comparison to a novel 23S rDNA real-time PCR assay 22 in HVs surgically removed for suspected, proven active, or healed IE. In these patients, the first five criteria were negative, with the exception of a moderately elevated C-reactive protein level. Patients classified as having valve diseases but no IE had HV analyses on a routine basis because of an immunocompromised situation (patients on dialysis or patients with diabetes) or due to morphological alterations of the valve suspicious for IE to the surgeon. Preoperatively, six of these patients revealed suspicious echocardiographic findings and four also had increased C-reactive protein levels eventually due to previous urinary tract infection, pneumonia, or continuous dialysis. None of these patients had clinical signs for alternative explanations, e.g. collagen vascular disease. Demographic data are shown in Table 1 .
Cultivation and 16S rDNA polymerase chain reaction analysis of heart valves Heart valve tissues were aseptically disrupted in a sterile mortar and cultivated in tryptone soya broth and brain heart infusion bouillon (bioMérieux, Nürtingen, Germany) at 378C under aerobic and anaerobic conditions for a maximum of 21 days, as well as on Columbia sheep blood agar and chocolate agar at 378C for 5 days, 5% CO 2 . All isolates were identified by morphology and the biochemical identifying methods ID 32C and VITEK 2 ID-YST (bioMérieux). Total DNA was extracted from the second part of the valve using the QIAamp DNA blood kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. DNA was eluted from the QIAamp column with 50 mL sterile distilled water. Broad-range bacterial 16S rDNA PCR followed by sequencing analysis was performed as described previously.
23
Real-time polymerase chain reaction analysis assay developed for the amplification of the 23S rRNA gene 22 was adapted for the detection of the 23S rDNA gene. For all assays, the validity of PCR results was confirmed using exogenous internal controls. We modified the internal control of the 23S rDNA assay to avoid competitive co-amplification of the b2-microglobulin gene using a 278 bp fragment of the bacteriophage lambda (position 2214-2471, accession number J02459). The internal MS2 control of the 28S rDNA assay 24 was adapted for the mycoplasmal tuf assay.
Cut-off values were routinely set to 0.01 relative fluorescence units. The analytical sensitivity of the 23S rDNA real-time PCR assay was determined by a 10-fold dilution of the DNA extract from a Staphylococcus aureus infected HV with negative sample material. External plasmid standards were used to determine the concentration of bacterial DNA. Plasmid standards of the complete 23S rDNA of S. aureus strain ATCC25923 from position 1490 (16S-23S internal transcribed spacer, accession number J01859) to position 2763 (23S rDNA, accession number J01859) were established. 23 The samples were analysed in triplicate in three independent PCR assays. The bacterial concentration was determined by relative quantification using the ratio of the b2-microglobulin and 23S rDNA C T values. Quantitative real-time PCR was performed 22 with the following modification: amplification was accomplished in two separate PCR assays to avoid competitive inhibition due to high concentrations of human b2-microglobulin copies.
Statistical analysis
All calculations for statistical analysis were performed using GraphPad Prism 4.0 software (GraphPad Software, San Diego, CA, USA). Values are given as mean including standard deviation (+SD). Testing for Gaussian distribution utilized the Kolmogorov-Smirnov test. We used Pearson and Spearman correlation coefficients to assess correlations between two variables (two-sided testing). P-values ,0.05 were considered significant.
Results
Routine analysis of heart valve samples by culture and 16S rDNA polymerase chain reaction
Microorganisms were identified in 160 (45%) out of 357 surgically removed HVs. Application of 16S rDNA PCR detected bacterial DNA in 149 of these 160 HVs (93%), HV cultures were positive in 64 HVs (40%), and both were positive in 53 HVs. In 96 of these 160 HVs, bacterial DNA was detected by PCR, whereas HV cultures remained negative. Cultures of valve specimens were positive in 15 out of 160 HVs, while no bacterial DNA was detected by PCR. These 160 HVs came from 141 patients in whom IE had been proved according to the modified Duke criteria pre-operatively. Blood cultures were positive in 109 of these patients. Figure 1 demonstrates the results of PCR and HV cultures with respect to the causative organism and the duration of preoperative antibiotic treatment. All pathogens were identified to species level, but are given as genus in Figure 1 . PCR facilitated the detection of Streptococcus spp. with an almost equal frequency independent of the duration of antibiotic treatment. Heart valve cultures detected Streptocococcus spp. primarily within the first 10 days of antibiotic treatment. Staphylococcus spp. had a maximum recovery rate within 20 (PCR) and 10 days The 16S rDNA PCR results were coincident with those from HV cultures, with the exception of five patients. In these patients, PCR results corresponded with pathogens previously isolated from blood culture. In 23 HVs (21 patients), pathogens identified by PCR and from blood cultures were inconsistent. Sequencing analysis exposed minor differences regarding species identification in 13 patients: species identifications differed in seven patients, whereas in six patients, causative microorganisms had been identified only to genus, not to species level from previously drawn blood cultures, and identification was first proved by sequencing analysis of HV tissue. In eight patients, sequencing analysis obtained inconsistent results already on the level of genus identification. For example, Pasteurella multocida or coagulase-negative Staphylococci were identified from blood culture, whereas Actinobacillus actinomycetemcomitans or Streptococcus pneumoniae were identified from HV tissue.
No infective agent was identified by 16S rDNA PCR in 208 (58%) of the 357 removed valves. This high frequency of negative 16S rDNA PCR represents the routine setting where PCR testing was performed irrespective of clinical or infectious patient parameters. Analysis of the medical reports revealed that 88 HVs were removed from patients with non-infective valve disease, 47 from patients with healed IE, and only 36 from patients with active IE, and 37 from patients with an ambiguous infective status. After excluding 135 HVs removed from patients who had either a non-inflammatory heart disease or a healed IE, identification of an infective agent by 16S rDNA PCR still remained negative in 73 (33%) of 222 HVs.
The comparison of the 16S rDNA PCR detection rate for prosthetic HVs and native HVs in patients with active IE or an ambiguous infective status revealed a considerable lower frequency for prosthetic valves (52%) compared with native valves (69%), whereas the positive findings in HV culture were nearly equivalent for both groups (prosthetic valves: 31%, native valves: 29%).
Comparison of bacterial polymerase chain reaction assays
The comparison of real-time 23S rDNA PCR results with a routine analysis of HV samples by 16S rDNA, and HV cultures are given in Table 2 . No positive results were obtained by 16S rDNA PCR in patients classified as no IE or healed IE. Heart valve cultures were positive for six HVs; however, the second culture with oppositional culture conditions did not reveal growth, indicating possible contamination. Regarding all patients with active IE at the time of surgery, positive 16S rDNA PCR results were obtained in 149 of 185 HVs (80.5%), whereas the cultures of HV tissue were positive in only 63 of 185 HVs (34.0%). In addition to the standard 16S rDNA PCR, remaining samples of retained DNA extracts (n ¼ 200) were examined and quantified by real-time PCR targeting the bacterial 23S rDNA, the fungal 28S rDNA, and the mycoplasmal tuf gene. Head-to-head comparison of 16S rDNA and 23S rDNA real-time PCR is given in Table 2 . 23S rDNA real-time PCR revealed positive PCR results in 107 of 111 specimens (96.4%) from patients with active IE. 16S rDNA PCR results were negative in 16 of these HVs. Only 23S rDNA real-time PCR detected bacterial DNA in 11 HVs of patients whose infective status was considered ambiguous and in five HVs of patients with clinically healed IE since 2 -10 months. 28S rDNA real-time PCR confirmed fungal DNA in two valves, concordant to HV culture results. Mycoplasma spp. was not found in any of the examined HVs. No PCR inhibition or contamination of PCR reagents or sample material was detected using real-time PCR assays. The efficacy of 23S rDNA real-time PCR was lower in explanted prosthetic HVs (72% positive 23S rDNA findings in patients with active IE or ambiguous infective status) than in native valves (94% positive results).
Sensitivity, specificity, positive, and negative predictive values
The diagnostic sensitivities, specificities, positive predictive value (PPV), and negative predictive value (NPV) for the 16S rDNA assay, the 23S rDNA assay, HV culture, WBC, and C-reactive protein are given in Table 2 . PCR assays detect IE pathogens in 80.5% (16S rDNA), and 96.4% (23S rDNA), both with a specificity and a PPV of 100.0%, while 16S rDNA had an NPV of 71.0% Quantification of bacterial DNA in heart valve samples and correlation with inflammatory markers
The analytical sensitivity of the 23S rDNA real-time PCR assay was determined to 35 -100 copies/PCR reaction. In comparison, the 16S rDNA PCR assay revealed a 10 -100-fold lower sensitivity. Bacterial DNA was quantified in 116 HVs of 104 patients with an active, an ambiguous infective status, or healed IE. In the case of two or more analysed HVs per patient, the bacterial load was averaged. The mean concentration of the bacterial load, C-reactive protein, and WBC decreased parallel to the duration of antibiotic treatment (Figure 2 Tested/total, n (%) Tested/total, n (%) Tested/total, n (%) Tested/total, n (%) Tested/total, n (%) Mean value (+ + + + +SD) Tested/total, n (%) Mean value (+ + + + +SD) however, was found between C-reactive protein and WBC (r ¼ 0.5, P , 0.0001).
Discussion
The causative microorganism is unknown in up to 50% of patients undergoing HV surgery for IE. 1 The importance of PCR techniques has been evaluated in many studies. However, study results are limited by technical issues, the number of HVs analysed, a restricted range of detectable microorganisms, the taxonomic level of bacterial identification, consideration of antibiotic therapy, and limited controls to confirm the validity of PCR results. 8,9,11 -16 In the present study, we demonstrate for the first time that the ultrasensitive 23S rDNA real-time PCR is superior to the conventional standard 16S rDNA PCR for the detection of the infective agent in surgically removed HVs from IE patients.
Polymerase chain reaction techniques
16S rDNA PCR facilitates the identification of causative pathogens, as shown for T. whipplei 23 or Bartonella spp., 26 but 16S rDNA realtime PCR is often subject to environmental contamination. Applying 16S rDNA conventional PCR, approximately 20% of HVs removed during active IE remain false-negative. 18, 19 In our study, the causative pathogen could not be detected in 33% of infected HVs. It is known that quantitative real-time PCR applications achieve higher diagnostic sensitivities, 19 but for the detection of pathogens in HVs, 16S
rDNA real-time PCR has been used successfully in only one study. 10 For the first time, we utilized 23S rDNA as a target for realtime amplification combined with the application of internal controls to confirm the validity of PCR results. This technique allowed increasing the sensitivity to detect IE pathogens from 80.5 to 96.4% (compared with 16S rDNA conventional PCR). Both PCR techniques revealed specificities and a PPV of 100%, but with 23S rDNA, a higher NPV (92.5 vs. 71.0%) was obtained. The advantage of 23S rDNA over 16S rDNA as a target for real-time PCR is essentially due to the fact that contaminations are only seen when using 16S rDNA. 10, 19 In patients with an ambiguous infectious status, and in patients with active IE but negative conventional PCR results, real-time PCR improved the diagnostic sensitivity of PCR by more than 50%. Unfortunately, the PCR product of 23S rDNA real-time PCR is short, not allowing the identification of the pathogen to species level, which, however, can easily be done with 16S rDNA conventional PCR. For the subsequent examination of HVs, we suggest routine detection of pathogens by 23S rDNA real-time PCR followed by 16S rDNA conventional PCR to identify the pathogen to species level when appropriate. The algorithm shown in Figure 3 represents a pathology-based approach to verify clinically diagnosed or suspected IE. Future investigations will address the extension of the amplification region of the 23S rDNA to facilitate species identification by sequencing analysis directly after 23S rDNA real-time PCR amplification.
PCR techniques have become a standard application to overcome inherent limitations of culture methods, facilitating a rapid diagnosis of infectious diseases. In the present study, PCR applications were focused on the detection of microorganisms in HVs. This restricts its potential role in routine clinical practice to patients with active IE requiring HV replacement. We also performed molecular genetic whole blood testing using the 23S rDNA PCR assay in 33 patients with IE (unpublished data), but the detection of bacterial pathogens in whole blood by PCR often failed due to the low amount of bacteria. We demonstrated that the PCR analysis of HVs is more successful, probably due to the higher concentration of pathogens. The main incremental value of PCR analysis in HVs is the detection and identification of microorganisms especially in patients without previous pathogen detection to allow an optimized antimicrobial treatment. In nine patients with CNE and in 22 patients without positive blood culture results prior to surgery, the identification of the causative pathogen using 16S rDNA PCR had a major impact on antibiotic therapy. Subsequently, 27 of these 31 patients had a favourable outcome with a rapid resolution of inflammation. Only four patients developed relevant post-operative complications (e.g. heart failure treated with intra-aortic balloon counterpulsation and catecholamines, long-term mechanical ventilation, acute renal failure). Application of 23S rDNA real-time PCR confirmed the presence of bacteria in two further HVs of patients with CNE. Sequencing analysis of HVs revealed inconsistent results compared with blood cultures in eight patients in whom antibiotic treatment was changed accordingly after species had been identified by PCR. The antibiotic therapy was not altered in those 13 patients with different species identification between HV PCR and blood culture results because the initially established antibiotic resistogram reflected the effective antibiotic susceptibilities of the underlying causative pathogens. In these cases, 16S rDNA PCR may offer an improved species identification and differentiation between closely related species, which are not achieved by biochemical identifying methods (e.g. differentiation between Streptococcus mitis and Streptococcus oralis applying ID 32C and VITEK 2 ID-YST).
Infective endocarditis due to fungal or mycoplasmal pathogens is rare. Most epidemiological data were derived from small case series or case reports. The importance of Candida endocarditis, particularly in intravenous drug abusers and immunocompromised patients, is growing. 27, 28 For this reason, we included rapid realtime PCR screening for fungal and mycoplasmal spp. in our diagnostic strategy, and detected two valves infected by Candida spp. To optimize the PCR results of HVs we learned from cases of active IE with negative PCR results, even utilizing the ultrasensitive 23S rDNA real-time technique, that it is important to examine an appropriate section of the HV as bacterial colonization is definitely not uniform. For example, transmission electron microscopy of tissue infected with Bartonella henselae revealed areas with tight bacterial colonization and non-infected areas. 26 The partitioning of the surgically removed HV into several pieces for histology, culture, and PCR examinations has to be done carefully to avoid sampling errors.
Influence of antibiotic treatment on identification of causative pathogens
Blood cultures and tissue cultures of HVs from patients with active IE are hampered by antibiotic treatment. 1 In our study, tissue cultures from infected HVs provided positive results if antibiotics had been given for less than 11 days prior to surgery. Positive tissue culture results decreased significantly if antibiotic therapy lasted longer. Polymerase chain reaction identified bacterial DNA mainly within the first 20 days of antibiotic treatment, but even after longer treatment periods, a significant number of positive results were found. The highly sensitive real-time PCR assay successfully detected bacterial DNA after more than 40 days of effective antibiotic treatment. Furthermore, the persistence of bacterial DNA was documented in valves from patients with healed IE. The infectious potential of the microorganism, the degree of tissue infiltration, and the effect of antibiotics all influence the retention of pathogens.
1,29
Bacterial load in explanted heart valves To the best of our knowledge, bacterial load in explanted infected HVs was measured in this study for the first time. Parallel to the duration of antibiotic therapy, bacterial load, as well as C-reactive protein and WBC, decreased. High bacterial loads after 31 -40 days and high values for C-reactive protein after more than 40 days of antibiotic treatment indicated inadequate antibiotic treatment. In this series, the lack of correlation among bacterial load and C-reactive protein or WBC might be explained by long-term persistence of bacterial DNA and the sampling error by partitioning of the HV.
Pathogen viability
The presence of bacterial DNA does not necessarily indicate the presence of viable bacteria. To distinguish between acute disease and DNA persistence, a careful simultaneous consideration of clinical symptoms, laboratory, and microbiological findings is mandatory. Long-term persistence of bacterial DNA may be explained by: (i) a recurrent infection; (ii) the initial infection that was not resolved completely due to deep valve penetration, or was not curable even by adequate antibiotic treatment, 1, 29 and bacteria remained viable but non-growable; (iii) PCR-detected DNA from killed bacteria. We observed long-term persistence, particularly in cases with Streptococcus spp. None of the patients classified as healed had any clinical evidence of infection at the time of surgery; thus, the assumption of DNA persistence in the debris of healed cardiac vegetations seems to be obvious. However, the implication of long-term bacterial persistence for the patient is unclear. Presence of viable, but not yet growable, bacteria may predispose for recurrences. Future applications should address the usage of additional reverse transcription real-time PCR assays based on the amplification of mRNA targets, such as hsp60 or elongation factor TU, 30, 31 to provide additional information about pathogen viability.
In conclusion, examination of explanted HVs by PCR, especially in patients with CNE, allows identification of the causative pathogen and improves stratification of antimicrobial therapy. Positive culture results have the advantage to allow antimicrobial sensitivity testing. If blood and/or HV culture results are negative or unreliable, positive PCR results from explanted HVs offer important information. For the examination of HVs, we suggest the following diagnostic strategy: (i) ultrasensitive screening for bacterial DNA using real-time PCR in parallel to HV cultivation in cases of suspected or definite active IE, (ii) in case of positive results, identification of the causative microorganism by 16S rDNA PCR followed by sequencing analysis, (iii) in case of negative results, additional examination by real-time PCR for the detection of not yet detected bacterial pathogens, including fungal or mycoplasmal pathogens. The detection of bacterial DNA in HVs does not implicate an active valve infection as so far PCR cannot differentiate viable from non-viable microorganisms. The state of infection has to be classified by consideration of clinical, laboratory, and microbiological findings of the patient.
Study limitations
The retrospective character of this study hampered the application of additional diagnostic approaches (e.g. repeated collection of blood cultures, molecular genetic screening of whole blood), but our results showed that 23S rDNA real-time PCR analysis of explanted HVs is helpful to detect causative microorganism with a very high sensitivity. Although our cohort included only a small number of patients with ambiguous infective status or healed IE, the PCR results revealed the known general limitation of PCR analysis to distinguish between viable pathogens and persisting DNA. Therefore, the infective status of a patient cannot be determined or monitored by PCR analysis.
